TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
BMEA

Biomea Fusion Inc

Healthcare · Biotechnology

1.50$ +3.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BMEA
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
100.0% 99.5% 95.1% 91.1% 89.6% 85.5% 99.1%
90.2% 98.7% 78.5% 86.5% 88.5% 72.9% 95.3%
90.2% 98.7% 93.4% 87.4% 88.5% 72.9% 95.3%
– 0.5% 3.1% 4.5% – – –
107.9% 91.7% 3.7% 16.1% 15.4% 35.5% 49.5%
107.9% 2.6% 2.5% 14.8% 11.4% 27.1% 19.0%
– 0.4% 0.3% 0.5% 1.2% 2.6% 2.5%
102.3% 1.2% 0.7% 5.3% 3.4% 16.2% 5.5%
-7.9% 8.3% 96.3% 83.9% 84.6% 64.5% 50.5%
-1,075.8% -13.1% -26.8% -101.8% -124.5% -484.4% -766.7%
4,040.8% 17.1% 12.8% 22.6% 17.1% 45.2% 89.2%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?